Has the Hong Kong Trade Companies and Distributors Industry valuation changed over the past few years?

Investors are pessimistic on the Hong Kong Trading Companies and Distributors industry, indicating that they anticipate long term growth rates will be lower than they have historically. The industry is trading at a PE ratio of 16.0x which is lower than its 3-year average PE of 24.1x. The industry is trading close to its 3-year average PS ratio of 0.55x.

How does Hong Kong Trade Companies and Distributors compare with similar industries?

There is insufficient data on the sub-industries of this industry.

Hong Kong (HSI) Trade Companies and Distributors Industry Analysis

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Tue, 16 Aug 2022	HK$147.7b	HK$340.5b	HK$9.4b	6.2x	15.7x	0.4x
Thu, 14 Jul 2022	HK$155.0b	HK$339.9b	HK$9.0b	6.2x	17.2x	0.5x
Sat, 11 Jun 2022	HK$159.8b	HK$339.7b	HK$9.2b	9.8x	17.3x	0.5x
Mon, 09 May 2022	HK$157.2b	HK$334.7b	HK$9.2b	9.6x	17.1x	0.5x
Wed, 06 Apr 2022	HK$162.1b	HK$343.1b	HK$8.8b	9.7x	18.5x	0.5x
Fri, 04 Mar 2022	HK$164.0b	HK$302.6b	HK$10.8b	13.2x	15.3x	0.5x
Sun, 30 Jan 2022	HK$150.5b	HK$301.2b	HK$12.2b	11.2x	12.4x	0.5x
Tue, 28 Dec 2021	HK$150.1b	HK$300.5b	HK$12.2b	11.2x	12.3x	0.5x
Thu, 25 Nov 2021	HK$148.2b	HK$299.8b	HK$12.1b	10.5x	12.2x	0.5x
Sat, 23 Oct 2021	HK$161.1b	HK$291.4b	HK$11.1b	13.1x	14.6x	0.6x
Mon, 20 Sep 2021	HK$167.3b	HK$289.7b	HK$10.4b	12.7x	16.1x	0.6x
Wed, 18 Aug 2021	HK$161.2b	HK$296.4b	HK$10.9b	11x	14.8x	0.5x
Wed, 02 Jun 2021	HK$158.6b	HK$266.1b	HK$9.1b	13.4x	17.5x	0.6x
Sat, 06 Mar 2021	HK$148.2b	HK$245.7b	HK$6.0b	11.2x	24.8x	0.6x
Tue, 08 Dec 2020	HK$138.8b	HK$235.4b	HK$5.9b	10.2x	23.7x	0.6x
Mon, 31 Aug 2020	HK$123.8b	HK$222.9b	HK$3.0b	12.7x	41.7x	0.6x
Thu, 04 Jun 2020	HK$107.9b	HK$227.6b	HK$4.2b	9.4x	25.6x	0.5x
Sun, 08 Mar 2020	HK$136.6b	HK$236.8b	HK$6.8b	11.5x	20.2x	0.6x
Sat, 30 Nov 2019	HK$143.8b	HK$230.1b	HK$3.2b	12.7x	45.4x	0.6x
Tue, 03 Sep 2019	HK$162.8b	HK$237.7b	HK$3.0b	13x	54.5x	0.7x


HK Market	-0.16%
Industrials	-1.45%
Trade Distributors	-1.81%
Trade Companies and Distributors	-1.81%

Company	Last Price	7D	1Y	Valuation
9878 Huitongda Network	HK$62.00	2.1% +HK$731.3m	n/a	PS0.5x
166 New Times Energy	HK$0.16	6.0% +HK$79.3m	185.7%	PE4.3x
8196 China TianYF Holdings Group	HK$1.66	18.6% +HK$78.0m	654.5%	PS2.8x
1660 Zhaobangji Properties Holdings	HK$0.48	1.0% +HK$31.0m	-14.9%	PE79.1x
217 China Chengtong Development Group	HK$0.15	3.5% +HK$29.8m	-18.0%	PE8.4x

Jul 16

CAA Resources Limited Announces Appointment of Jin Young Woo as Chief Scientist and Research Team

The board of directors of CAA Resources Limited announced that Jin Young Woo has been appointed as the Chief Scientist by Grace Generation Investment Limited, a wholly owned subsidiary of the Company. He is joined by a team of Senior Scientist Dr. Lee Eun Kyong, and three experienced Research Associates. These five specialists have over more than 20 years of dedicated research in the plant stem cell and have been obtaining over 96 plant cell related technology and application patents registered in 41 countries globally. Jin Young Woo Mr. Jin will lead the research team and be mainly responsible for formulating research and development strategy of innovative products in drug, food, and cosmetics applications, and promoting international collaborations. Mr. Jin, aged 49, reputed to be the "father of plant cell stem", has been the forefront pioneer leading the discovery of the plant stem cell studies with applications ranging from extracting compounds for drug development, functional food, and function cosmetics. His botanical drug development has been adopted in the areas of anticancer ingredient, AIDS, liver function, and even swine fever disease. Ginseng, ginkgo stem cells, for instance, are one of the wildly researched plants by Jin and his team in the medical field to extract many useful medical ingredients to address different diseases. The future prospect in pharmaceutical, food, and cosmetic applications by plant stem cell innovation is destined to be very promising. Mr. Jin has been leading a few Korean government sponsored international researches in the field of anticancer agent through the transformation of cell, anti-oxidant and anti-inflammatory functional food using plant stem cells, function materials for immune enhancement, and anti- aging materials and cosmetics. Jin has regular academic papers published in international journals such as Journal of Pharmacy and Pharmacology, Life Science, Journal of Ginseng Research, New Biotechnology, etc. He served as editorial board member of Journal of Traditional Chinese Medicine for more than 10 years until August 2021. He filed and successfully obtained 92 patents. Besides, he is a successful businessman as well with numerous awards by local chamber of commerce in Korea. Jin has been smart to blend research and business in the course of managing the tech business. Lee, Eun-Kyong Dr. Lee, aged 39, is both academia and entrepreneur who has successful track record to commercialize successfully in Korea. She obtained her PhD pursuing botany in Jeonbuk University, Korea in 2001. Ever since her graduation, she has been focusing on plant stem cell research and business development. She has been the Head of Institute, Plant Stem Cell Institute of Korea. Dr. Lee has participated in numerous academic research sponsored by national funding and Chaebol such as LG; the research areas cover from cosmetics, food, and diseases. Her academic papers have been published in renowned journals such as New Biotechnology, Asia Health Care Journal, Pharmaceutical Biology, Journals of Medical Plant Research, etc. She has registered approximately 102 patents herself. One of her specialization is the study of anti-aging, anti wrinkle, and whitening effect of ginseng and ginkgo stem cells. The ginseng stem cells research, for instance, enables extension of application to discover anti-HIV ingredients where Dr. Lee has been following since 2009. The functional material through plant stem cell extracts have been proven to be effective to inhibit many diseases such as cancer cell proliferation inhibition, immunity enhancement. Anti-aging is one substantial areas where plant stem cells have material impact. The commercialization value is tremendous and bright prospect where the Company relies on the new team to guide on product launch forthcoming.

Jun 28

China Chengtong Development Group Limited Announces Executive Changes

China Chengtong Development Group Limited announced that Mr. Wang Daxiong has been appointed as a non-executive director and a member of the Audit Committee of the Company, both of which will take effect from 1 July 2022. The Board also announces that it has resolved to establish an ESG Committee with effect from 1 July 2022. Upon the establishment of the ESG Committee, Mr. Wang Daxiong will act as the chairman of the committee, and Mr. Yang Tianzhou and Professor He Jia will act as the members of the committee, all of which will take effect from 1 July 2022. Mr. Wang, aged 61, obtained a bachelor's degree in economics, majoring in shipping finance and accounting, from Shanghai Maritime University in 1983 and a master's degree in business administration for senior management from Shanghai University of Finance and Economics in 2012. He is a Senior Accountant. Mr. Wang has nearly 40 years of experience in the shipping industry. He worked in Guangzhou Shipping Bureau of the Ministry of Transport of the People's Republic of China from August 1983 to January 1996 mainly responsible for finance matters and afterwards in Guangzhou Shipping (Group) Co. Ltd. as the head of finance department and chief accountant until January 1998. From January 1998 to March 2014, Mr. Wang served various positions in China Shipping (Group)Company successively, including chief accountant, vice president and deputy general manager. During the period from August 1997 to March 2014, Mr. Wang had been an executive director of China Shipping Development Company Limited (currently known as COSCO SHIPPING Energy Transportation Co. Ltd.) (a company listed on the Main Board of The Stock Exchange of Hong Kong Limited ("SEHK") and the Shanghai Stock Exchange ("SSE") with stock codes01138 and 600026 respectively). In addition, Mr. Wang acted as a non-executive director of China Merchants Bank Co. Ltd. (a company currently listed on the Main Board of the SEHK and on the SSE with stock codes 03968 and 600036 respectively) during the period from 1998 to 2014 and also subsequently from November 2016 to the present. Mr. Wang had been a non-executive director of COSCO SHIPPING Development Co. Ltd. (a company listed on the Main Board of the SEHK and on the SSE with stock codes 02866 and 601866 respectively) from 2004 to 2014 and had subsequently acted as its executive director and chairman of the board of directors since May 2016 until his resignation on 16 June 2022. He also acted as a non-executive director of China Merchants Securities Co. Ltd. (a company listed on the Main Board of the SEHK and on the SSE with stock codes 06099 and 600999 respectively) from September 2016 to May 2022. In May 2022, Mr. Wang was appointed as an independent director of (unofficial English name being Chengtong Securities Co. Ltd.), which is a non-wholly owned subsidiary of the Company's ultimate holding company, China Chengtong Holdings Group Limited. Pursuant to the proposed appointment letter to be entered into between Mr. Wang and the Company, Mr. Wang will be appointed as a NED for a term of one year commencing from 1 July 2022, subject to retirement by rotation and re-election and other related provisions as stipulated in the articles of association of the Company and the Rules Governing the Listing of Securities on the Stock Exchange.

Hong Kong (HSI) Trade Companies and Distributors Industry Analysis

Industry Valuation and Performance

Industry Comparison

Top Stock Gainers and Losers

Latest News

1341

Here's Why Hao Tian International Construction Investment Group (HKG:1341) Has A Meaningful Debt Burden

8196

Second quarter 2022 earnings released: EPS: CN¥0.007 (vs CN¥0.006 loss in 2Q 2021)

1001

Upcoming dividend of HK$0.015 per share

2588

Consensus forecasts updated

166

New Times Energy Corporation Limited Provides Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

1231

Newton Resources Ltd to Report First Half, 2022 Results on Aug 25, 2022

9878

Huitongda Network Co., Ltd. to Report First Half, 2022 Results on Aug 23, 2022

990

Theme International Holdings Limited Provides Earnings Guidance for the Six Months Period Ended 30 June 2022

1660

Full year 2022 earnings released: EPS: HK$0.006 (vs HK$0.014 in FY 2021)

2866

Investor sentiment deteriorated over the past week

2112

CAA Resources Limited Announces Appointment of Jin Young Woo as Chief Scientist and Research Team

1104

Now 27% undervalued after recent price drop

217

China Chengtong Development Group Limited Announces Executive Changes

2098

Co-Chairman recently sold HK$5.0m worth of stock

1196

Realord Group Holdings (HKG:1196) Is Carrying A Fair Bit Of Debt

2102

Tak Lee Machinery Holdings (HKG:2102) May Have Issues Allocating Its Capital